Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Some drugs used to treat inflammation may cause hair loss.

The FDA did not approve a testosterone drug because of safety concerns.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A toddler with unusual hypothyroidism symptoms improved with levothyroxine treatment.

Correcting selenium and zinc levels may help manage hair loss in autoimmune thyroiditis.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Applying thyroid hormone T3 speeds up wound healing in mice.

Tofacitinib treatment is used for teenagers with alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Thyroid problems can negatively affect women's reproductive health and pregnancy, and can cause symptoms like fatigue and depression, but not all women with these symptoms need treatment.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

The patient's hypothyroidism improved with medication adjustments and careful management.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Thyroid function affects skin health, with a complex interaction between the two.